T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
28 hedge funds and large institutions have $1.55M invested in T2 Biosystems, Inc in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 4 closing their positions.
257% more call options, than puts
Call options by funds: $25K | Put options by funds: $7K
200% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 4
131% more capital invested
Capital invested by funds: $672K → $1.55M (+$880K)
40% more funds holding
Funds holding: 20 → 28 (+8)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$818K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$711K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$600K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$573K |
| 5 |
Walleye Capital
New York
|
+$427K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ML
McAdam LLC
Philadelphia,
Pennsylvania
|
-$58K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$47K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$6.88K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$5.68K |
| 5 |
Morgan Stanley
New York
|
-$1.31K |
TTOO Hedge Fund Activity: Q1 2023 in Review
28 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2023, worth a combined $1.55M — up 131% from $672K a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new TTOO positions and 4 closed out — a net gain of 8 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $818K. The largest seller was McAdam LLC, exiting entirely with an estimated $58K sold.
- 28 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2023, up from 20 in Q4 2022.
- Funds reported $1.55M of T2 Biosystems, Inc stock for Q1 2023, up 131% quarter-over-quarter.
- 12 funds opened new T2 Biosystems, Inc positions in Q1 2023 and 4 closed out, a net change of +8 holders.
- The largest T2 Biosystems, Inc buyer in Q1 2023 was Sabby Management, an estimated $818K added.
- The largest T2 Biosystems, Inc seller in Q1 2023 was McAdam LLC, an estimated $58K sold.
Based on aggregated 13F filings for Q1 2023.